This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...

The FDA issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side ...

Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and ...

Ozempic and Wegovy users who have suffered blindness, vomiting and even the loss of a loved one have warned about the 'dark ...

Downside to dropping pounds? The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side effects. Historically, semaglutide, the active ingredient in Ozempic and ...

Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...

Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but can be serious, a new study found Compounded versions of semaglutide could explain some of these visits, ...

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

Researchers have identified the brain cells responsible for the weight-loss effects of semaglutide without triggering its undesirable side effects. This discovery paves the way for more targeted and ...

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...